Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Rafael Holdings, Inc.RFL · Entity 6620 | Chief Devel. & Medical Officer | October 18, 2021 | October 19, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Rafael Holdings, Inc.
Report date October 18, 2021 · Filed October 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.54 · Expires 2031-10-17 | Direct | 122,341 |
Reported balance
After 2021-10-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-10-18 · Grant · Acquired 122,341 · Balance 122,341 F1: Options vest as follows: 25% shall vest on October 18, 2022 and additional equity with respect to 2.0833% of the options shall vest on each monthly anniversary thereafter, such that all equity shall vest by October 18, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest as follows: 25% shall vest on October 18, 2022 and additional equity with respect to 2.0833% of the options shall vest on each monthly anniversary thereafter, such that all equity shall vest by October 18, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 18, 2021 Filed Oct 19, 2021 19:48 UTC | Rafael Holdings, Inc. RFL · Entity 6620 | GrantEmployee Stock Option (right to buy) · Derivative | 122,341 | $0.00 Strike: $30.54 | $0.00 |
DisclosureSEC source: 0001209191-21-060875 · doc4.xml · derivative · entry 1 HUIZINGA MARY MARGARET · CIK 0001888166 · Chief Devel. & Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,341 Underlying: Class B Common Stock · 122,341 shares Expires 2031-10-17 F1 · derivative.exercise_date: Options vest as follows: 25% shall vest on October 18, 2022 and additional equity with respect to 2.0833% of the options shall vest on each monthly anniversary thereafter, such that all equity shall vest by October 18, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.